BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2002
View Archived Issues
Three series of MMP inhibitors prepared and tested at former Warner-Lambert
Read More
Antimyeloma efficacy of PS-341 in a human plasmacytoma xenograft model
Read More
Antitumor activity of IDN-5109 against hormone-refractory prostate cancer
Read More
Antisense oligonucleotide to ICAM-1 ameliorates chronic intestinal inflammation in transgenic rats
Read More
NXY-059 exerts neuroprotective effects in rat model of acute stroke
Read More
Deltagen discovers novel antibody target for potential treatment of rheumatoid arthritis
Read More
Ceregene receives SBIR grant for Alzheimer's disease gene therapy research
Read More
Novel series of PDE4 inhibitors in early development at Altana
Read More
New mGluR1 modulators for use in neuropathic pain and other disorders
Read More
Bayer researchers describe novel factor Xa inhibitors
Read More
Scientists at Ajinomoto synthesize inhibitors of activation of inflammatory factors
Read More
Amine salts of alphavbeta3 antagonist and their use in osteoporosis claimed by Merck
Read More
Novel antiproliferative macrolides prepared by Kosan researchers
Read More
CRF antagonists in early development at Neurocrine Biosciences
Read More
CV Therapeutics presents novel fatty acid oxidation inhibitors for cardiovascular disorders
Read More
Pfizer identifies potent, selective, orally active sorbitol dehydrogenase inhibitor
Read More
Phase II results of dapsone in Alzheimer's disease
Read More
Second phase of RADIUS trial initiated
Read More
Phase II Multikine trial in head and neck cancer completes enrollment
Read More
Small-molecule MC4 receptor agonist with effects on food intake and erectile activity
Read More
First nonpeptide urotensin-II receptor agonist reported recently
Read More
Preclinical antibacterial activity, pharmacokinetics and toxicity of new PDF inhibitor
Read More
Well-established antiparasitic agent now reported to possess potent antitumor activity
Read More
New data on the safety and efficacy of topical tacrolimus in atopic dermatitis
Read More
Alefacept reported to be a valid therapeutic option for chronic psoriasis
Read More
Pegasys approved by FDA
Read More